Lannett gets FDA approval to resume sales of oxycodone capsules
August 04, 2014 at 12:26 PM EDT
The Food and Drug Administration granted marketing approval to Lannett Co. Inc. for its oxycodone hydrochloride capsules, ending a two-year-old dispute between the Northeast Philadelphia generic pharmaceutical company and the federal agency...